Concepedia

Rachna T. Shroff

RT

98

Publications

11.6K

Citations

46

H-Index

2008

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Arizona

University of Arizona Cancer Center

Massachusetts General Hospital

Memorial Sloan Kettering Cancer Center

Rachna T. Shroff is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pathology.

Top concepts

MedicineOncologyPathologyCancer ResearchRadiation OncologyCancer TherapyMolecular OncologyTumor BiologyPharmacologyCancer Genetics

Publications per year

2008–2025

98

Publications

98

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

Benjamin J. Raphael, Ralph H. Hruban, Andrew J. Aguirre et al. · Cancer Cell · 2017 · 2K citations · Full text

Functional Genomics, Pancreatic Cancer, Pathology +6

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Ghassan K. Abou‐Alfa, Teresa Macarulla, Milind Javle et al. · The Lancet Oncology · 2020 · 995 citations · Full text

Gastrointestinal Oncology, Medicine, Biliary Cancer +8

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

Milind Javle, Maeve A. Lowery, Rachna T. Shroff et al. · Journal of Clinical Oncology · 2017 · 700 citations

Surgical Oncology, Pathology, Phase Ii Study +17

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

John D. Gordan, Erin B. Kennedy, Ghassan K. Abou‐Alfa et al. · Journal of Clinical Oncology · 2020 · 601 citations

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers

Rachna T. Shroff, Milind Javle, Lianchun Xiao et al. · JAMA Oncology · 2019 · 460 citations · Full text

Rows per page

1–5 of 98